Preface: Special issue: "Ion channels and genetic epilepsy"

Area of Science:

• Neuroscience
• Genetics
• Pharmacology

Background:

• Epilepsy is a neurological disorder with a high prevalence of treatment-resistant cases, indicating an unmet clinical need.
• Genetic factors, particularly mutations in ion channel genes, are increasingly recognized as key contributors to epilepsy pathogenesis.
• Despite advances in therapeutics, a significant portion of epilepsy patients remain refractory to standard treatments.

Discussion:

• Reviews in this special issue cover epilepsy associated with variations in HCN channels, voltage-dependent sodium and calcium channels, and GABA_A receptors.
• The interplay between metabolic factors and ion channel function in genetic epilepsy is explored.
• Research investigates the potential of existing drugs to correct NMDA receptor dysfunction and utilizes in vitro neuron cultures to study network deficits in SCN2A disease.

Key Insights:

• Understanding genotype-phenotype relationships is crucial for developing targeted epilepsy therapies.
• Precision medicine approaches are emerging as a promising strategy for managing epilepsy.
• Ion channel dysfunction is a central theme in understanding the genetic basis of epilepsy.

Outlook:

• Future research directions include exploring metabolic therapies and the gut microbiome's role in epilepsy.
• Development of novel in vivo screening tools aims to accelerate the discovery of new anti-seizure drugs.
• Continued investigation into genetic causes, especially those involving ion channels, will drive therapeutic innovation in epilepsy research.